Page last updated: 2024-11-05

zonisamide and Hamartoma

zonisamide has been researched along with Hamartoma in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arita, K1
Kurisu, K1
Iida, K1
Hanaya, R1
Akimitsu, T1
Hibino, S1
Pant, B1
Hamasaki, M1
Shinagawa, S1

Other Studies

1 other study available for zonisamide and Hamartoma

ArticleYear
Subsidence of seizure induced by stereotactic radiation in a patient with hypothalamic hamartoma. Case report.
    Journal of neurosurgery, 1998, Volume: 89, Issue:4

    Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Epilepsy, To

1998